(Q39261325)

10 September 2017

title

Measuring incidence of HTLV-1: the other human retrovirus (English)

1 reference

Human T-lymphotropic virus 1

10 September 2017

main subject

0 references

author name string

Sarah Mollenkopf

series ordinal

1

1 reference

10 September 2017

Edward L Murphy

series ordinal

2

1 reference

10 September 2017

publication date

23 August 2016

1 reference

Lancet Infectious Diseases

10 September 2017

published in

1 reference

10 September 2017

volume

16

1 reference

10 September 2017

issue

11

1 reference

10 September 2017

page(s)

1205-1206

1 reference

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

Epidemiological Aspects and World Distribution of HTLV-1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

Incidence of HIV and HTLV-I Infection Among Sexually Transmitted Disease Clinic Attenders in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930322-X

7 January 2021

10.1016/S1473-3099(16)30322-X

Identifiers

DOI

1 reference

10 September 2017

1 reference